SCHEMBL11229490

SCHEMBL11229490

CCOC(=O)C(=O)c1ccc2c(c1)[nH]c1ccc(Cl)cc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.51
MAPT P10636 3/20 0.51
KMT2A Q03164 3/20 0.51
ALDH1A1 P00352 3/20 0.51
KDM4E B2RXH2 2/20 0.51
HCRTR1 O43613 1/20 0.51
RAB9A P51151 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
PTGS2 P35354 4/20 0.49
ABCC4 O15439 1/20 0.49
C5 P01031 1/20 0.49
PTGS1 P23219 1/20 0.49
PDE4D Q08499 1/20 0.49
CYP1A2 P05177 1/20 0.47
HPGD P15428 1/20 0.47
XBP1 P17861 1/20 0.47
CYP2C19 P33261 1/20 0.47
ALOX15 P16050 4/20 0.47
KIF11 P52732 1/20 0.45
CSF1R P07333 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11233015 0.86 PTGS2 (0.52) MEN1MAPTKMT2APTGS2ABCC4
SCHEMBL11242478 0.84 KDM4E (0.63) MEN1MAPTKMT2AALDH1A1KDM4E
SCHEMBL11475780 0.81 PTGS2 (0.48) MEN1MAPTKMT2AALDH1A1KDM4E
SCHEMBL10774096 0.80 PTGS2 (0.54) MEN1MAPTKMT2AALDH1A1KDM4E
SCHEMBL11239778 0.80 PTGS2 (0.57) MEN1MAPTKMT2AKDM4EPTGS2
SCHEMBL10888116 0.78 KIF11 (0.66) MEN1MAPTKMT2APTGS2ABCC4
SCHEMBL70604 0.77 ALDH1A1 (0.81) MEN1MAPTKMT2AALDH1A1KDM4E
SCHEMBL20515867 0.77 MEN1 (0.59) MEN1MAPTKMT2AALDH1A1KDM4E
Methane SCHEMBL28638234 0.77 ALOX15 (0.50) MEN1MAPTKMT2AALDH1A1PTGS2
SCHEMBL11398303 0.77 PTGS2 (0.71) MEN1MAPTKMT2AALDH1A1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170158637-A1 Synthetic Processes of Carprofen CHEMWERTH, INC. 2017-06-08 US disclosed
US-20170158637-A1 Synthetic Processes of Carprofen CHEMWERTH, INC. 2017-06-08 US disclosed
US-9611217-B2 Synthetic processes of carprofen CHEMWERTH, INC. (US) 2017-04-04 US disclosed
US-9611217-B2 Synthetic processes of carprofen CHEMWERTH, INC. (US) 2017-04-04 US disclosed
US-20160326113-A1 Synthetic Processes of Carprofen CHEMWERTH, INC. 2016-11-10 US disclosed
US-20160326113-A1 Synthetic Processes of Carprofen CHEMWERTH, INC. 2016-11-10 US disclosed
EP-3091000-A1 SYNTHETIC PROCESS OF CARPROFEN ChemWerth, Inc. (US) 2016-11-09 EP disclosed
EP-0006606-B1 PROCESS FOR THE PREPARATION OF CARBAZOLES AND INTERMEDIATES THEREFOR F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1982-12-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160326113-A1 Synthetic Processes of Carprofen CYP4F2, CYP4F3, CYP2J2 MEN1 4524/4885MAPT 4647/4885KMT2A 3710/4885
US-20170158637-A1 Synthetic Processes of Carprofen CYP4F2, CYP4F3, CYP2J2 MEN1 4524/4885MAPT 4647/4885KMT2A 3710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.